Point72 Asset Management
AXSM icon

Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Point72 Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$3.65M – 3779
2025
Q4 		$3.65M Buy
20,000
+5,900
+42% +$824K ﹤0.01% 2062
2025
Q3 		$1.71M Hold
14,100
– – ﹤0.01% 1503
2025
Q2 		$1.47M Buy
14,100
+200
+1% +$21.2K ﹤0.01% 1424
2025
Q1 		$1.62M Sell
13,900
-700
-5% -$79.7K ﹤0.01% 1307
2024
Q4 		$1.24M Buy
14,600
+1,700
+13% +$156K ﹤0.01% 1414
2024
Q3 		$1.16M Hold
12,900
– – ﹤0.01% 1366
2024
Q2 		$1.04M Buy
12,900
+6,100
+90% +$452K ﹤0.01% 1263
2024
Q1 		$543K Buy
+6,800
New +$571K ﹤0.01% 1626

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return